aria.labels.skip_content

Belgian registry for molar pregnancies and other trophoblastic diseases

Trophoblastic diseases, such as molar pregnancies, happen when the placenta develops in an unusual way. These conditions are rare and usually not cancerous, affecting about 1 in 1,000 pregnancies.

Patient

The mission of the registry is to improve the care of patients with trophoblastic diseases. Through the links below, you can find more information about the registry and trophoblastic diseases as a patient.

Healthcare professional

The mission of the registry is to improve the care of patients with trophoblastic diseases. Through the links below, you can find more information about the registry and trophoblastic diseases as a healthcare professional.

Better care through knowledge

Trophoblastic diseases are rare, which can make diagnosis, treatment, and follow-up challenging. The Belgian Registry aims to improve patient care and deepen medical understanding. With patients' consent, we offer to register these conditions in collaboration with their physician, in order to document these rare diseases, monitor patient cases, and provide guidance on appropriate management.

By participating, patients and healthcare professionals contribute to better outcomes and future advancements in care.

 Together, we enhance treatment and knowledge!

Do you want to register a patient or do you have questions?

Registration of a patient is possible via the button 'Register a patient'.

Do not hesitate to contact us in case of questions, You can do so via the button 'Contact us'.

Publications & Meetings

Here you can follow the research with an overview of the recent publications and future meetings.
Rio2026
Meetings

ISSTD - XXIII WORLD CONGRESS ON GESTATIONAL TROPHOBLASTIC DISEASE

The XXIII ISSTD World Congress on Gestational Trophoblastic Disease will be held in Rio de Janeiro from November 10 to 13, 2026.
Artikel
Publications

Practical Guidelines for the Treatment of Gestational Trophoblastic Disease

This publication summarizes the international guidelines jointly developed by the four leading scientific societies dedicated to gestational trophoblastic disease.